Tourettism, hemiballism and juvenile parkinsonism: Expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden-Spatz syndrome);Touretismo, hemibalismo y parkinsonismo juvenil: Expandiendo el espectro clínico de la neurodegeneración asociada a deficiencia de pantotenato cinasa (síndrome de Hallervorden-Spatz)

Revista de Neurologia

Volumn 38, Issue 4, 2004, Pages 327-331

  Carod Artal, Francisco Javier ^a   Vargas, A P ^a   Marinho, P B ^a   Fernandes Silva, T V ^a   Portugal, D ^a  

^a SARAH NETWORK OF REHABILITATION HOSPITALS   (Brazil)

Author keywords

Dystonia; Eye of the tiger; Hallervorden Spatz syndrome; Hemibalism; Pantothenate kinase associated neurodegeneration; Tourette syndrome

Indexed keywords

APOLIPOPROTEIN B; BETA N ACETYLHEXOSAMINIDASE A; GANGLIOSIDE GM1; LEVODOPA; PANTOTHENATE KINASE;

ADOLESCENT; ADULT; AMINOACIDURIA; ARTICLE; ATONIC SEIZURE; BASAL GANGLION; BEHAVIOR DISORDER; BODY POSTURE; CASE REPORT; CHOREA; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GILLES DE LA TOURETTE SYNDROME; GLOBUS PALLIDUS; GM1 GANGLIOSIDOSIS; HEMIBALLISM; HUMAN; HUNTINGTON CHOREA; HYPOBETALIPOPROTEINEMIA; IRON METABOLISM; JOINT INSTABILITY; MALE; MOTOR DYSFUNCTION; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PALILALIA; PARKINSONISM; RETINITIS; RETINITIS PIGMENTOSA; RIGIDITY; SANDHOFF DISEASE; SYNDROME DELINEATION; TIC; WILSON DISEASE;

EID: 1842508200     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3804.2003346     Document Type: Article

References (29)

1. Hallervorden J, Spatz H. Eigenartige erkrankung im extrapyramidalen system mit besonderer beteiligung des globus pallidus und der substantia nigra. Z Gesamte Neurol Psychiatr 1922; 79: 254-302.
2. Dooling EC, Schoene WC, Richardson EP. Hallervorden-Spatz syndrome. Arch Neurol 1974; 30: 70-83.
3. Swaiman KF. Hallervorden-Spatz syndrome. Pediatr Neurol 2001; 25: 103-8.
4. Savoiardo M, Halliday WC, Nardocci N, Strada L, D'Incerti L, Angelini L, et al. Hallervorden-Spatz syndrome: MR and pathologic findings. AJNR Am J Neuroradiol 1993; 14: 155-62.
5. Sethi KD, Adams RJ, Loting DW, El Gammal T. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 1988; 24: 692-4.
6. Hayflick SJ, Penzien JM, Michl W, Sharif UM, Rosman NP, Wheeler PG. Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome. Pediatr Neurol 2001; 25: 166-9.
7. Shevell MI, Peiffer J. Julius Hallervorden's wartime activities: implications for science under dictatorship. Pediatr Neurol 2001; 25: 162-5.
8. Racette BA, Perry A, D'Avossa G, Perlmutter JS. Late-onset neurodegeneration with brain iron accumulation type 1: expanding the clinical spectrum. Mov Disord 2001; 16: 1148-52.
9. Taylor TD, Litt M, Kramer P, Pandolfo M, Angelini L, Nardocci N, et al. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet 1996; 14: 479-81.
10. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nature Genet 2001; 28: 345-9.
11. Klepper J, Schaper J, Raca G, Coryell J, Das S, Hayflick SJ, et al. Progressive dystonia in a 12-year-old boy. Eur J Paediatr Neurol 2003; 7: 85-8.
12. Angelini L, Nardocci N, Rumi V, Zorzi C, Strada L, Savoiardo M. Hallervorden-Spatz syndrome: clinical and MRI study of 11 cases diagnosed in life. J Neurol 1992; 239: 417-25.
13. Vaher U, Napa A, Nurmiste A, Piirsoo A, Silbul H, Talvik T. Four siblings with Hallervorden-Spatz disease. Brain Dev 2001; 23: 236-9.
14. Hickman SJ, Ward NS, Surtees RAH, Stevens JM, Farmer SF. How broad is the phenotype of Hallervorden-Spatz disease? Acta Neurol Scand 2001; 103: 201-3.
15. Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching KHL, et al. Genetic, clinical and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003; 348: 33-40.
16. Ching JHL, Westaway SK, Gitschier J, Higgins JJ, Hayflick SJ. HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration. Neurology 2002; 58: 1673-4.
17. Vasconcelos OM, Harter DH, Duffy C, McDonough B, Seidman JG, Seidman CE, et al. Adult Hallervorden-Spatz syndrome simulating amyotrophic lateral sclerosis. Muscle Nerve 2003; 28: 118-22.
18. Jankovic J, Kirkpatrick JB, Blomquist KA, Langlais PJ, Bird ED. Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism. Neurology 1985; 35: 227-34.
19. Grimes DA, Lang AE, Bergeron C. Late adult onset chorea with typical pathology of Hallervorden-Spatz syndrome. J Neurol Neurosurg Psychiatry 2000; 69: 392-5.
20. Alberca R, Rafel E, Chinchón I, Vadillo J, Navarro A. Late onset parkinsonian syndrome in Hallervorden-Spatz disease. J Neurol Neurosurg Psychiatry 1987; 50: 1665-8.
21. Koeppen AH, Dickson AC. Iron in the Hallervorden-Spatz syndrome. Pediatr Neurol 2001; 25: 148-55.
22. Castelnau P, Zilbovicius M, Ribeiro MJ, Hertz-Pannier L, Ogier H, Evrard P. Striatal and pontocerebellar hypoperfusion in Hallervorden-Spatz syndrome. Pediatr Neurol 2001; 25: 170-4.
23. Buruma OJS, Lakke JP. Ballism. In Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of clinical neurology: extrapiramidal disorders. Amsterdam: Elsevier Science Publishers; 1986. p. 369-80.
24. Jankovic J. Tics in other neurological disorders. In Kurlan R, ed. Handbook of Tourette's syndrome and related tic and behavioral disorders. New York: Marcel Dekker; 1993. p. 167-82.
25. Vargas AP, Carod-Artal FJ, Bomfim D, Vázquez-Cabrera C, Dantas-Barbosa C. Unusual early onset Huntington's disease. J Child Neurol 2003; 18: 429-32.
26. Scarano V, Pellecchia MT, Filla A, Barone P. Hallervorden-Spatz syndrome resembling a typical Tourette syndrome. Mov Disord 2002; 17: 618-20.
27. Nardocci N, Rumi V, Combi ML, Angelini L, Mirabile D, Bruzzone MG. Complex tics, stereotypes, and compulsive behavior as clinical presentation of a juvenile progressive dystonia suggestive of Hallervorden-Spatz syndrome. Mov Disord 1994; 9: 369-71.
28. Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001; 28: 350-4.
29. Gitlin JD. Aceruloplasminemia. Pediatr Res 1998; 44: 271-6.